Outlook Therapeutics Inc (NASDAQ: OTLK) closed up on Friday. What’s in store for the next week?
OTLK closed Friday at $2.09, up by 7.73%. More than 746K shares traded hands. The stock opened at the lowest point of the session at $1.96 and moved within a wide range of $1.96-$2.11.
OTLK Released Quarterly Earnings
On Friday, the OTLK issued a press release. Here are quick notes:
Outlook Therapeutics Reports Financial Results for Second Quarter of Fiscal Year 2021 and Provides Corporate Update
- Outlook Therapeutics reported a net loss attributable to common stockholders of $13.1 million, or $0.09 per basic and diluted share, compared to a net loss attributable to common stockholders of $17.5 million, or $0.36 per basic and diluted share for the same period last year.
- On March 31, 2021, Outlook Therapeutics had cash and cash equivalents of $37.2 million, compared to $5.6 million on December 31, 2020.
- With the $42.6 million in gross proceeds received from the public offerings and private placements of common stock in February 2021 plus an additional $3.6 million received from warrant exercises also in February 2021, Outlook Therapeutics’ cash and cash equivalents on hand are sufficient to fund operations through November 2021.
OTLK is trading below its 50-day of $2.15, but well above its 200-day moving average of $1.46. The stock has jumped 60.77% so far this year.
|+/- EMA(20)||2.12 (-1.42%)|
|+/- SMA(50)||2.15 (-2.79%)|
|+/- SMA(200)||1.46 (+43.15%)|
|SHARES OUTSTANDING||173.61 M|
|SHARE FLOAT (%)||88.45 M (50.95%)|
|% HELD BY INSTITUTIONS||7.76|